scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41436-019-0561-7 |
P698 | PubMed publication ID | 31263214 |
P50 | author | Priya S Kishnani | Q83248117 |
Carine Halaby | Q88868481 | ||
P2093 | author name string | Brian Smith | |
Sarah P Young | |||
Stephanie Austin | |||
Gary R Schooler | |||
Deeksha Bali | |||
Alisha M Mavis | |||
Surekha Pendyal | |||
Lani K Clinton | |||
Jariya Upadia | |||
Ela Stefanescu | |||
P2860 | cites work | Molecular analysis of the AGL gene: heterogeneity of mutations in patients with glycogen storage disease type III from Germany, Canada, Afghanistan, Iran, and Turkey. | Q54575766 |
Molecular analysis of the AGL gene: Identification of 25 novel mutations and evidence of genetic heterogeneity in patients with Glycogen Storage Disease Type III | Q56697963 | ||
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment | Q67720940 | ||
Urinary excretion of a glucose-containing tetrasaccharide. A parameter for increased degradation of glycogen | Q67928042 | ||
Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy | Q68116950 | ||
The Subgroups of Type III Glycogenosis | Q70923890 | ||
Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinoma. The Liver Transplant Group | Q73107781 | ||
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease | Q74067512 | ||
Fatal liver cirrhosis and esophageal variceal hemorrhage in a patient with type IIIa glycogen storage disease | Q77950626 | ||
Elevated serum biotinidase activity in hepatic glycogen storage disorders--a convenient biomarker | Q81579416 | ||
Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children | Q83525974 | ||
Hepatocellular Adenomas and Carcinoma in Asymptomatic, Non-Cirrhotic Type III Glycogen Storage Disease | Q86961871 | ||
Role of continuous glucose monitoring in the management of glycogen storage disorders | Q88868484 | ||
Glycogen storage disease type III diagnosis and management guidelines | Q28287932 | ||
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis C | Q30360178 | ||
Liver transplantation for glycogen storage disease types I, III, and IV | Q33797826 | ||
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology | Q34465792 | ||
Markedly elevated serum transaminases in glycogen storage disease type III | Q35206365 | ||
Characterization of a canine model of glycogen storage disease type IIIa | Q36359220 | ||
Cardiac Pathology in Glycogen Storage Disease Type III | Q36590950 | ||
Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? | Q36695473 | ||
Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome. | Q37180852 | ||
Mouse model of glycogen storage disease type III. | Q39234934 | ||
Type III glycogenosis presenting as liver disease in adults with atypical histological features | Q39508441 | ||
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature | Q41460619 | ||
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. | Q42982768 | ||
Glycogen storage disease type III: A novel Agl knockout mouse model. | Q43433907 | ||
Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution–electrospray ionization tandem mass spectrometry | Q44414194 | ||
Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values | Q44458156 | ||
A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. | Q44527614 | ||
A simple, rapid test for the differential diagnosis of glycogen storage disease type 3. | Q44555356 | ||
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 | ||
Role of two-dimensional shear wave elastography in the assessment of chronic liver diseases | Q46487453 | ||
Circulating fibroblast growth factor 21 in patients with liver cirrhosis | Q48027127 | ||
Late presentation of glycogen storage disease types Ia and III in children with short stature and hepatomegaly | Q49642749 | ||
Chronic hepatitis. An update on terminology and reporting. | Q53635198 | ||
P433 | issue | 12 | |
P921 | main subject | glycogen storage disease | Q1421738 |
P304 | page(s) | 2686-2694 | |
P577 | publication date | 2019-07-02 | |
P1433 | published in | Genetics in Medicine | Q15765508 |
P1476 | title | Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring | |
P478 | volume | 21 |
Q97423859 | A Novel Gene Therapy Approach for GSD III Using an AAV Vector Encoding a Bacterial Glycogen Debranching Enzyme |
Q92994170 | Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency |
Q89739213 | Dietary lipids in glycogen storage disease type III: A systematic literature study, case studies, and future recommendations |
Q97885773 | Normalization of obstructive cardiomyopathy and improvement of hepatopathy on ketogenic diet in patient with glycogen storage disease (GSD) type IIIa |
Q97517813 | Response to Heiner-Fokkema et al |
Q97517804 | The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases |
Q94553548 | Urine glucose tetrasaccharide: A good biomarker for glycogenoses type II and III? A study of the French cohort |
Search more.